PPISURV: a novel bioinformatics tool for uncovering the hidden role of specific genes in cancer survival outcome

被引:53
作者
Antonov, A. V. [1 ,2 ]
Krestyaninova, M. [3 ]
Knight, R. A. [1 ]
Rodchenkov, I. [4 ]
Melino, G. [1 ,2 ,5 ]
Barlev, N. A. [2 ,6 ,7 ]
机构
[1] Univ Leicester, Med Res Council, Toxicol Unit, Leicester LE1 9HN, Leics, England
[2] Technol Univ, Mol Pharmacol Lab, St Petersburg, Russia
[3] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland
[4] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada
[5] Univ Roma Tor Vergata, Dept Expt Med & Surg, Rome, Italy
[6] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England
[7] Russian Acad Sci, Inst Cytol, Gene Express Programme, St Petersburg 194064, Russia
基金
英国医学研究理事会;
关键词
bioinformatics; computational oncology; survival; P73 TRANSCRIPTIONAL ACTIVITY; BREAST-CANCER; PROGNOSTIC MARKER; MICROARRAY DATA; ONLINE TOOL; P53; BIOMARKERS; RESOURCE; DATABASE; THERAPY;
D O I
10.1038/onc.2013.119
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Multiple clinical studies have correlated gene expression with survival outcome in cancer on a genome-wide scale. However, in many cases, no obvious correlation between expression of well-known tumour-related genes (that is, p53, p73 and p21) and survival rates of patients has been observed. This can be mainly explained by the complex molecular mechanisms involved in cancer, which mask the clinical relevance of a gene with multiple functions if only gene expression status is considered. As we demonstrate here, in many such cases, the expression of the gene interaction partners (gene 'interactome') correlates significantly with cancer survival and is indicative of the role of that gene in cancer. On the basis of this principle, we have implemented a free online datamining tool (http://www.bioprofiling.de/PPISURV). PPISURV automatically correlates expression of an input gene interactome with survival rates on >40 publicly available clinical expression data sets covering various tumours involving about 8000 patients in total. To derive the query gene interactome, PPISURV employs several public databases including protein-protein interactions, regulatory and signalling pathways and protein post-translational modifications.
引用
收藏
页码:1621 / 1628
页数:8
相关论文
共 29 条
[1]
MIRUMIR: an online tool to test microRNAs as biomarkers to predict survival in cancer using multiple clinical data sets [J].
Antonov, A. V. ;
Knight, R. A. ;
Melino, G. ;
Barlev, N. A. ;
Tsvetkov, P. O. .
CELL DEATH AND DIFFERENTIATION, 2013, 20 (02) :367-367
[2]
BioProfiling.de: analytical web portal for high-throughput cell biology [J].
Antonov, Alexey V. .
NUCLEIC ACIDS RESEARCH, 2011, 39 :W323-W327
[3]
R spider: a network-based analysis of gene lists by combining signaling and metabolic pathways from Reactome and KEGG databases [J].
Antonov, Alexey V. ;
Schmidt, Esther E. ;
Dietmann, Sabine ;
Krestyaninova, Maria ;
Hermjakob, Henning .
NUCLEIC ACIDS RESEARCH, 2010, 38 :W78-W83
[4]
NCBI GEO: archive for high-throughput functional genomic data [J].
Barrett, Tanya ;
Troup, Dennis B. ;
Wilhite, Stephen E. ;
Ledoux, Pierre ;
Rudnev, Dmitry ;
Evangelista, Carlos ;
Kim, Irene F. ;
Soboleva, Alexandra ;
Tomashevsky, Maxim ;
Marshall, Kimberly A. ;
Phillippy, Katherine H. ;
Sherman, Patti M. ;
Muertter, Rolf N. ;
Edgar, Ron .
NUCLEIC ACIDS RESEARCH, 2009, 37 :D885-D890
[5]
Bcl-2 is a prognostic marker in breast cancer independently of the Nottingham Prognostic Index [J].
Callagy, GM ;
Pharoah, PD ;
Pinder, SE ;
Hsu, FD ;
Nielsen, TO ;
Ragaz, J ;
Ellis, IO ;
Huntsman, D ;
Caldas, C .
CLINICAL CANCER RESEARCH, 2006, 12 (08) :2468-2475
[6]
Castiglione F, 1999, ANTICANCER RES, V19, P4555
[7]
Inhibition of bcl-2 as cancer therapy [J].
Ciardiello, F ;
Tortora, G .
ANNALS OF ONCOLOGY, 2002, 13 (04) :501-502
[8]
Reactome: a database of reactions, pathways and biological processes [J].
Croft, David ;
O'Kelly, Gavin ;
Wu, Guanming ;
Haw, Robin ;
Gillespie, Marc ;
Matthews, Lisa ;
Caudy, Michael ;
Garapati, Phani ;
Gopinath, Gopal ;
Jassal, Bijay ;
Jupe, Steven ;
Kalatskaya, Irina ;
Mahajan, Shahana ;
May, Bruce ;
Ndegwa, Nelson ;
Schmidt, Esther ;
Shamovsky, Veronica ;
Yung, Christina ;
Birney, Ewan ;
Hermjakob, Henning ;
D'Eustachio, Peter ;
Stein, Lincoln .
NUCLEIC ACIDS RESEARCH, 2011, 39 :D691-D697
[9]
BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received [J].
Dawson, S-J ;
Makretsov, N. ;
Blows, F. M. ;
Driver, K. E. ;
Provenzano, E. ;
Le Quesne, J. ;
Baglietto, L. ;
Severi, G. ;
Giles, G. G. ;
McLean, C. A. ;
Callagy, G. ;
Green, A. R. ;
Ellis, I. ;
Gelmon, K. ;
Turashvili, G. ;
Leung, S. ;
Aparicio, S. ;
Huntsman, D. ;
Caldas, C. ;
Pharoah, P. .
BRITISH JOURNAL OF CANCER, 2010, 103 (05) :668-675
[10]
CCancer: a bird's eye view on gene lists reported in cancer- related studies [J].
Dietmann, Sabine ;
Lee, Wanseon ;
Wong, Philip ;
Rodchenkov, Igor ;
Antonov, Alexey V. .
NUCLEIC ACIDS RESEARCH, 2010, 38 :W118-W123